Coronary CT angiography has been increasingly used in the diagnosis of coronary artery disease due to rapid technological developments, which are reflected in the improved spatial and temporal resolution of the images. High diagnostic accuracy has been achieved with 64-and more slice CT scanners and in selected patients, coronary CT angiography is regarded as a reliable alternative to invasive coronary angiography.
Introduction
Coronary artery disease (CAD) is the leading cause of mortality and morbidity in developed countries. The diagnosis and management of CAD is increasingly dependent on non-invasive imaging modalities. Recent technological advances have led to a considerable increase in image quality for coronary imaging using multislice CT. [1] [2] [3] Numerous studies have shown that coronary CT angiography (CCTA), as a less-invasive alternative to coronary angiography, has a high diagnostic accuracy for the detection of significant CAD (≥50% lumen stenosis) when compared to invasive coronary angiography. [3] [4] [5] [6] [7] [8] [9] High quality multislice CT (64-slice and higher) is not only able to provide reliable information on coronary luminal changes, but also has the potential to visualise coronary artery wall morphology, characterise atherosclerotic plaques and identify non-stenotic plaques that may be undetected by conventional coronary angiography. Studies have shown that CCTA demonstrates high prognostic value in CAD, as it is able to differentiate low-risk from high-risk patients [10] [11] [12] , with very low rate of adverse cardiac events occurring in patients with normal CCTA, and significantly high rate of these events in patients with obstructive CAD.
It has been a regular procedure to perform both coronary artery calcium (CAC) scoring and CCTA for diagnosis in patients with suspected CAD. Results dealing with the incremental prognostic value of CAC scoring used in combination with CCTA have recently been published. 13 Although satisfactory results have been achieved in these studies, with strengths and weaknesses being addressed, very few studies have specifically examined the clinical applications of CCTA in the particular target population, or risk stratification and assessment with regard to the judicious use of 5 CCTA. [14] [15] [16] Identification of the exact role of CCTA in patients from different risk groups is clinically significant as this could lead to unnecessary examinations due to the fact that multislice CT is an imaging modality with high radiation dose. In addition, 
Current status of coronary CT angiography in coronary artery disease
With recent progress in the technical developments of multislice CT scanners, images can be acquired in a very short time with very high spatial resolution. In particular, the development of 64-or more slice CT scanners allows acquisition of cardiac images with a temporal resolution that is a fraction of the length of the cardiac cycle with an isotropic volume resolution of less than 0.5 mm. 9, 17 Non-diagnostic CCTA studies have decreased from 15-25% with the early generation of 4-and 16-slice CT scanners to less than 10% with 64-slice CT scanners. 17, 18 The cost of performing a CCTA examination is much lower than that of an invasive coronary angiography, and is equivalent to an imaging stress test. Unlike invasive coronary angiography, which is associated with procedure-related complications, CCTA is a less invasive modality with very rare 6 occurrence of complications resulting from CT examinations. Consequently, there has been extensive interest in the clinical application of CCTA in the evaluation of patients with suspected CAD.
Most studies have reported the diagnostic accuracy of CCTA by coronary artery segment, coronary artery and per patient assessment. Several meta-analyses of studies on the use of 64-slice CT reported mean sensitivities and specificities ranging from 85% to 99%, and 86% to 96%, respectively. 3, 8, 19, 20 Given the dependence of positive predictive value and negative predictive value on the prevalence of disease, the relatively high prevalence of significant CAD as determined by invasive coronary angiography in many of these selected study populations compared to the general population raises a concern in appraising the value of CCTA in clinical practice. It has been shown that significant statistical heterogeneity exists among published studies, with smaller studies reporting higher diagnostic accuracy of CCTA in CAD. 21 Two recent multicentre studies discussed several methodological limitations of CCTA, as patients with high calcium scores were excluded from the analysis of one study, while in another study, no segments were excluded from the analysis despite high calcium scores, 4, 6 Therefore, reports of the diagnostic value of CCTA in CAD in the literature need to be interpreted with caution.
Coronary artery calcium scoring -predictive value in CAD
Quantifying the amount of coronary artery calcium with unenhanced CT calcium scoring has been widely accepted as a reliable non-invasive technique for screening risk of future cardiac events 22, 23 , and is usually quantified by using the Agatston score or scores such as the volume score or calcium mass. [24] [25] [26] Clinical application of CAC has been supported by evidence showing that absence of calcium reliably excludes obstructive coronary artery stenoses 27 , and that the amount of CAC is a strong predictor for risk assessment of myocardial infarction and sudden cardiac death, independent of conventional coronary risk factors. [28] [29] [30] However, the prognostic value of CAC depends on the risk groups as to whether patient risk is reclassified and patient management can be changed based on CAC scores when compared to traditional risk assessments. 31 The
Framingham risk score is one of the most commonly used risk-estimation systems, which enables clinicians to estimate cardiovascular risk in asymptomatic patients. It is calculated using traditional risk predictors, including age, gender, total cholesterol, highdensity lipoprotein cholesterol, smoking status, and systolic blood pressure, and is represented as a 10-year risk score for the prediction of coronary heart disease events. 32 However, there is growing evidence to show that these traditional risk assessment methods, based on risk factor analysis, have significant limitations when used to guide individual patient therapy. [32] [33] [34] CAC score by multislice CT has been increasingly used as an additional assessment tool to evaluate the risk of developing major cardiac events in asymptomatic and symptomatic patients.
Coronary artery calcium scoring-predictive value in asymptomatic patients
In asymptomatic individuals, zero CAC is associated with a very low (<1% per year) risk of major cardiac events over the next 3-5 years, whereas in asymptomatic patients with extensive coronary calcification, the major cardiac events have been reported to be increased by up to 11-fold. 35-37 Several large population-based studies have reported that in asymptomatic patients without known CAD, CAC is predictive of future cardiac events above and beyond traditional risk factors [38] [39] [40] . The recent population-based multiethnic study of atherosclerosis, conducted in 6,722 asymptomatic patients belonging to 8 four racial ethnic groups and followed for 3.8 years, showed a significant difference in the prevalence of CAC among different ethnic groups. Nonetheless, CAC has demonstrated incremental prognostic value over traditional risk factors, with a seven-fold increase in the incidence of cardiac events for Agatston scores >100 when compared with patients with zero CAC. 38 Other studies evaluating the prognostic value of the measurement of CAC have shown that coronary calcification is predictive of cardiac events in asymptomatic patients with different age groups. [39] [40] [41] LaMonte et al. in their study consisting of nearly 11,000
patients ranging from 22 to 96 years of age who underwent a screening medical examination, reported increased cardiac events in patients with coronary calcium scores of 400 or more during a mean follow-up of 3.5 years. 40 In the Prospective Army Coronary Calcium Project among men and women 40 to 45 years of age, Talyor et al.
concluded that the presence of coronary calcium was associated with an increase in the risk of coronary events by a factor of 12 during 3 years of follow-up. 39 Similarly, higher calcium scores were found to be associated with the relative risks of coronary events in the population-based Rotterdam Study of elderly asymptomatic patients.
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Coronary calcium score-prognostic value in symptomatic patients
Coronary calcification is considered only marginally related to the degree of coronary stenosis and it is well known that both obstructive and non-obstructive CAD can occur in the absence of calcification. [42] [43] [44] Significantly, coronary stenoses are frequently found to be non-calcified, and highly calcified plaques are frequently non-obstructive. Thus, the value of a zero or low calcium score (a low coronary calcium score is defined as an However, the contrast enhancement in the coronary artery vessels may obscure detection of plaque, especially the presence of extensively calcified plaques, and thus may obviate reliable measurements of plaque density. CCTA was found to underestimate higher Agatston scores. 48 It has been reported in that study that CCTA allows for the detection of CAC with high accuracy, as well as good correlation with unenhanced CT calcium score. In contrast, in patients with zero or low calcium score, CCTA was found to provide additional valuable information on patient management as CCTA detected obstructive coronary lesions in 7% of patients with a zero score and in 17% with a low CAC score. Their study indicated that in symptomatic patients with a zero or low CAC score on CT CAC scoring can be used to exclude an acute or long-term coronary syndrome, whereas CCTA is recommended as the non-invasive test of choice in these patients. 48 Similarly, van Werkhoven et al. in their recent report showed that CCTA provided additional prognostic information regarding stenosis severity and plaque composition when compared to CAC score for risk stratification in patients with suspected CAD. Their study involved analysis of plaque composition with CCTA, and results showed that the number of segments with non-calcified plaques and the number of segments with mixed plaques was found to be independently associated with increased risk for adverse cardiac events.
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Coronary CT angiography in high-risk patients
The pre-test probability of CAD may have a significant impact on the diagnostic performance of the CT scan. Pre-test probability or likelihood is defined according to Diamond and Ferrester criteria, which are based on age, gender and symptomatic status. 51 Intermediate likelihood is defined as a pre-test probability between 13.4% and 87.2%, while low and high pre-test probability are defined as less than 13.4% and more than 87.2%, respectively. It is noticed that the diagnostic performance of CCTA is different in patients from different risk groups. The diagnostic accuracy of CCTA has been extensively studied in populations with a high pre-test likelihood for CAD. [17] [18] [19] [20] However, this population is unlikely to benefit from CCTA because most patients require invasive coronary angiography for the purpose of revascularisation. Meijboom et al. in their prospective study observed that, in patients with a high pre-test likelihood for CAD, interpretations using CCTA failed to significantly change the post-test probability of significant CAD. Thus, normal findings of CCTA did not result in a sufficient reduction 11 of the post-test probability to reliably rule out the presence of significant CAD. These data indicate that the majority of these symptomatic patients are likely to proceed to invasive coronary angiography despite the negative CCTA findings.
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CCTA is considered to be of limited clinical value in the evaluation of the high pre-test probability group. In patients with a high pre-test likelihood for significant stenosis, functional evaluation, such as myocardial perfusion imaging, may be more relevant than CCTA to determine the need for revascularisation.
Coronary CT angiography in low-and intermediate-risk patients
In contrast to the high pre-test probability group, patients with an intermediate or low middle-aged asymptomatic patients with 64-slice CT and noticed the prevalence of 22% atherosclerotic plaques in these patients. 56 These studies further testified that coronary CT angiography is a valuable imaging modality for detection of atherosclerotic changes in the low-to intermediate-risk patients.
Coronary CT angiography in asymptomatic patients
Despite the high diagnostic accuracy of coronary artery stenosis and prognostic power of CCTA in symptomatic patients, to date there have been very limited publications evaluating the prognostic potential of CCTA in asymptomatic patients. Although only limited data are available in asymptomatic patient populations, it is possible that CCTA is valuable for risk stratification in these patients, since CCTA can be used to detect atherosclerosis for long-term risk assessment. [57] [58] [59] The prevalence of atherosclerosis was reported to be 22% in a recent study consisting of 1,000 asymptomatic individuals undergoing CCTA, with 5% and 2% being observed in ≥50% CAD and ≥75% CAD, respectively. 57 Cardiac events occurred in 1.5% of individuals during a follow-up of 17 months, all of whom had atherosclerosis on CCTA. These data indicate that CCTA is 13 currently not acceptable as a general screening tool and CAC score testing may be a preferable option. However, non-invasive CCTA may potentially be used as a test in the workup of asymptomatic individuals with cardiac risk characteristics. [57] [58] [59] [60] It has been recently reported that performing CCTA before invasive coronary angiography is a cost-effective strategy in the management of patients without symptoms who have positive stress rest results. 59 It is generally believed that a patient at low risk who has a positive stress test result (such as treadmill ECG studies, stress echocardiography, and radionuclide stress studies) is often referred for cardiac catheterisation, especially when the positive stress test result is obtained in a preoperative workup. Halpern et al. in their study using decision tree analysis reported that when a patient with an expected CAD prevalence of less than 85% is found to have a positive test result, CCTA is a less expensive alternative to invasive coronary angiography. 59 Although most patients undergo screening for CAD with stress tests to obtain functional and perfusion information which is not available with CCTA, a meta-analysis on more than 35,000 patients with coronary angiography as the reference standard showed that only average sensitivity and specificity was achieved with stress echocardiography and SPECT. 61 Thus, the use of CCTA in asymptomatic patients can avoid unnecessary invasive cardiac angiography procedures.
Coronary CT angiography-radiation dose issue
Radiation exposure associated with coronary CT angiography has increased substantially over the past two decades and it is a major concern that needs to draw attention of both clinicians and manufacturers. The general view about radiation dose is that coronary CT angiography is associated with a risk of cancer development. The recent Biological
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Effects of Ionising Radiation (BEIR) VII provides a framework for estimating cancer risk associated with radiation exposure from ionising radiation. 62 According to the report, it is estimated that 1 in 1000 people will develop cancer due to an exposure of 10 mSv. 70 Their results showed no added benefit to the addition of CAC scoring to CCTA, although their study population was restricted to a relatively low-risk group. Further studies based on multicentres with inclusion of large sample size are required to confirm their initial results.
Summary and Conclusion
The introduction of CCTA has significantly changed the clinical diagnostic approach to CAD. There is no doubt that, in patients with clinical suspected CAD, CCTA plays a significant role in establishing or excluding the diagnosis. With a very high negative predictive value, CCTA is widely regarded as a reliable technique in clinical practice to exclude significant CAD.
Use of CCTA for diagnosis and risk assessment in patients with low or intermediate risk or pretest probability for coronary artery disease is favourably preferred, whereas in highrisk patients, CCTA is less favourably recommended. Use of non-contrast CT for coronary artery calcium scoring is considered an appropriate approach in low-and intermediate-risk patients for prediction of cardiac events, while in symptomatic or highrisk patients, its predictive value is less reliable due to high prevalence of non-calcified plaques. Appropriate selections of cardiac CT will have a significant impact on physician decision-making and performance that will guide appropriate patient management 
